MHRA authorises Moderna’s omicron-containing bivalent booster
Study results show the candidate has demonstrated significantly higher antibodies against Omicron
Read Moreby John Pinching | Aug 15, 2022 | News | 0
Study results show the candidate has demonstrated significantly higher antibodies against Omicron
Read Moreby John Pinching | May 24, 2022 | News | 0
Companies say that three-dose vaccine for children aged six months to five years old is 80% effective at preventing illness
Read Moreby John Pinching | Mar 18, 2022 | News | 0
The hybrid of Delta and Omicron, known as ‘Deltacron’, has been identified in France, Denmark and the Netherlands
Read Moreby John Pinching | Mar 17, 2022 | News | 0
The sub-variant combines mutations from both Omicron and Delta
Read Moreby Iona Everson | Jan 14, 2022 | News | 0
Djokovic drama causes a racket: so how would the UK respond?
Read Moreby Iona Everson | Dec 8, 2021 | News | 0
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully bypass vaccine protections.
Read Moreby PharmaTimes | Nov 30, 2021 | News | 0
The Scottish government aims to expand and advance their COVID-19 booster programme, following the six cases of the Omicron variant that were reported as of Monday 29 November. This decision is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI).
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
